Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00391729
Show Display Options
Rank Status Study
1 Completed A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: ABT-089;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.